Renin-angiotensin system inhibition in COVID-19 patients
Point of View
[키워드] ACE
ACE2
ACEi
ACEIs
acute respiratory syndrome
Angiotensin II type‑1 receptor blocker
Angiotensin-converting enzyme
angiotensin-converting enzyme 2
angiotensin-converting enzyme inhibitor
ARB
ARBs
Arterial hypertension
blocker
cell entry receptor
Chronic kidney disease
Clinical data
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 patient
drug
drugs
enzyme
Evidence
expression
globe
heart failure
Hypothesis
indicated
infections
inhibitor
likelihood
Lungs
outcome
receptor
recommendation
renin-angiotensin system
Research
risk
SARS-CoV-2
SARS-CoV‑2
Severe acute respiratory syndrome coronavirus 2
severe COVID-19
Treatment
[DOI] 10.1007/s12471-020-01439-5 PMC 바로가기 [Article Type] Point of View
[DOI] 10.1007/s12471-020-01439-5 PMC 바로가기 [Article Type] Point of View